UBS Group’s AMN Healthcare AMN Stock Holding History

UBS Group’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,900	Closed	-$198K	–	10265
2022 Q1	$198K	Buy	+1,900	New	+$197K	﹤0.01%	5377
2015 Q1	–	Sell	-1,000	Closed	-$20K	–	8754
2014 Q4	$20K	Buy	+1,000	New	+$17.2K	﹤0.01%	7654

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group's AMN Position: Q1 2026 in Review

UBS Group increased its AMN Healthcare (AMN) stake by 80% in Q1 2026, buying an estimated $7.33M and bringing the position to 867,976 shares worth $15.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2841.

UBS Group first reported a position in AMN in Q4 2014 and has held it in 46 quarters since. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

UBS Group held 867,976 shares of AMN Healthcare worth $15.9M as of Q1 2026.
UBS Group bought 385,357 AMN Healthcare shares in Q1 2026, an estimated $7.33M.
AMN Healthcare made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2841 holding.
UBS Group first reported a position in AMN Healthcare in Q4 2014 and has held it in 46 quarters since.
249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.